1. Home
  2. EVLV vs NBTX Comparison

EVLV vs NBTX Comparison

Compare EVLV & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVLV
  • NBTX
  • Stock Information
  • Founded
  • EVLV 2013
  • NBTX 2003
  • Country
  • EVLV United States
  • NBTX France
  • Employees
  • EVLV N/A
  • NBTX N/A
  • Industry
  • EVLV Computer peripheral equipment
  • NBTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVLV Technology
  • NBTX Health Care
  • Exchange
  • EVLV Nasdaq
  • NBTX Nasdaq
  • Market Cap
  • EVLV 1.4B
  • NBTX 1.3B
  • IPO Year
  • EVLV N/A
  • NBTX 2020
  • Fundamental
  • Price
  • EVLV $8.28
  • NBTX $19.30
  • Analyst Decision
  • EVLV Strong Buy
  • NBTX Strong Buy
  • Analyst Count
  • EVLV 4
  • NBTX 1
  • Target Price
  • EVLV $8.88
  • NBTX $8.00
  • AVG Volume (30 Days)
  • EVLV 2.5M
  • NBTX 145.1K
  • Earning Date
  • EVLV 11-13-2025
  • NBTX 09-30-2025
  • Dividend Yield
  • EVLV N/A
  • NBTX N/A
  • EPS Growth
  • EVLV N/A
  • NBTX N/A
  • EPS
  • EVLV N/A
  • NBTX N/A
  • Revenue
  • EVLV $121,011,000.00
  • NBTX $11,930,711.00
  • Revenue This Year
  • EVLV $31.07
  • NBTX N/A
  • Revenue Next Year
  • EVLV $17.67
  • NBTX $114.97
  • P/E Ratio
  • EVLV N/A
  • NBTX N/A
  • Revenue Growth
  • EVLV 36.64
  • NBTX N/A
  • 52 Week Low
  • EVLV $2.04
  • NBTX $2.76
  • 52 Week High
  • EVLV $8.91
  • NBTX $30.35
  • Technical
  • Relative Strength Index (RSI)
  • EVLV 56.91
  • NBTX 46.34
  • Support Level
  • EVLV $7.61
  • NBTX $23.31
  • Resistance Level
  • EVLV $8.31
  • NBTX $28.51
  • Average True Range (ATR)
  • EVLV 0.43
  • NBTX 2.31
  • MACD
  • EVLV 0.00
  • NBTX -1.27
  • Stochastic Oscillator
  • EVLV 64.51
  • NBTX 8.55

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc offers an AI-based touchless security screening. Its touchless security screening systems use artificial intelligence software, cloud services, and sensors to reliably detect dangerous weapons while ignoring harmless items like cell phones, laptops, and keys. It offers products for purchase under a multi-year security-as-a-service subscription pricing model that delivers ongoing value to customers, generates predictable revenue, and creates expansion and upsell opportunities. The firm operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a clinical-stage biotechnology company that has one operating segment, which focuses on developing product candidates that use its proprietary nanotechnology to transform cancer treatment by increasing the efficacy of radiotherapy. The company develops NanoXray products to help patients receiving radiotherapy by magnifying the effect of radiotherapy within tumor cells without increasing the dose to surrounding healthy tissues. Its product candidate is NBTXR3, a preclinical research program for cancer immunotherapies.

Share on Social Networks: